FdaApplication
NDA 021460
Identifiers
- fda_app_no: NDA021460
Properties
| Property | Value |
|---|---|
| applicant_name | BRISTOL MYERS SQUIBB CO |
| application_type | NDA |
| approval_date | 2002-10-21 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| METAGLIP | GLIPIZIDE; METFORMIN HYDROCHLORIDE | 2.5MG;250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| METAGLIP | GLIPIZIDE; METFORMIN HYDROCHLORIDE | 2.5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| METAGLIP | GLIPIZIDE; METFORMIN HYDROCHLORIDE | 5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
3 products